Valproate Sodium Injection shortage
Current 2 presentations · 2 manufacturers · first FDA posting Dec 30, 2020 · last update Oct 15, 2026
Manufacturers: Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Demand increase for the drug
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Next release November 2026. Check wholesalers for inventory. | Posted Dec 30, 2020 Updated Oct 15, 2026 |
| Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots will be available. Product will be made available as it is released. | Posted Dec 30, 2020 Updated Oct 14, 2026 |